Skip to main content
Fig. 7 | Microbiome

Fig. 7

From: Milk oligosaccharide-driven persistence of Bifidobacterium pseudocatenulatum modulates local and systemic microbial metabolites upon synbiotic treatment in conventionally colonized mice

Fig. 7

Systemic metabolome changes associated with synbiotic treatment. A NMDS plot of mouse serum metabolome at the final experimental time point, with metabolites highlighted that drive differentiation of samples, colored by treatment group; B serum 1,2-propanediol (μmol/g) by highly enriched (HE) and moderately enriched (ME) bifidobacteria categorization of synbiotic treated mice; and C liver and brain 1,2-propanediol for control (n = 3) and synbiotic (n = 3) mice from experimental trial one. NMDS was generated using Euclidian distance in two dimensions. Boxplots represent medians and interquartile range (IQR) with whisker end points equal to the maximum and minimum values below or above the median at 1.5 times the IQR. * p < 0.05

Back to article page